SDZ ENA 713 facilitates central cholinergic function and ameliorates spatial memory impairment in rats

Behavioural Brain Research

Volumn 83, Issue 1-2, 1997, Pages 229-233

  Ohara, Tatsuo ^a   Tanaka, Ken Ichi ^a   Fukaya, Hiroaki ^a   Demura, Nobutaka ^a   Iimura, Akiko ^a   Seno, Naoki ^a  

^a Sandoz Tsukuba Research Institute   (Japan)

Author keywords

acetylcholinesterase; basal forebrain lesion; choline acetyltransferase; extracellular acetylcholine; muscarinic receptor binding; spatial memory

Indexed keywords

CHOLINE ACETYLTRANSFERASE; DOPAMINE; IBOTENIC ACID; NORADRENALIN; RIVASTIGMINE; SEROTONIN;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN INJURY; CONFERENCE PAPER; CONTROLLED STUDY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SPATIAL MEMORY;

EID: 0031081195     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(97)86076-7     Document Type: Conference Paper

References (25)

1. [1] Connor, D.J., Langlais, P.J. and Thal, L.J., Behavioral impairments after lesions of the nucleus basalis by ibotenic acid and quisqualic acid, Brain Res., 555 (1991) 84-90.
2. [2] Davies, P. and Maloney, A.J.F., Selective loss of central cholinergic neurons in Alzheimer's disease, Lancet, 12 (1976) 1403.
3. [3] Dokla, C.P.J., Parker, S.C. and Thal, L.J., Tetrahydroaminoacridine facilitates passive avoidance learning in rats with nucleus basalis magnocellularis lesions, Neuropharmacology, 28 (1989) 1279-1282.
4. [4] Enz, A., Amstutz, R., Hofmann, A., Gmelin, G. and Kelly, P.H., Pharmacological properties of the preferentially centrally acting acetylcholinesterase inhibitor SDZ ENA 713. In: Kewitz, Thomsen and Bickel (Eds.), Pharmacological Interventions of Central Cholinergic Mechanisms in Senile Dementia (Alzheimer's Disease), W. Zuckschwerdt Verlag, Munich, 1989, pp. 271-277.
5. [5] Enz, A., Amstutz, R., Boddeke, H., Gmelin, G. and Malanowski, J., Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease, Prog. Brain Res., 98 (1993) 431-438.
6. [6] Glowinski, J. and Iversen, L.L., Regional studies of catecholamines in the rat brain-I, J. Neurochem., 13 (1966) 655-669.
7. [7] Hardy, J., Adolfsson, R., Alafuzoff, I., Bucht, G., Marcusson, J., Nyberg, P., Perdahl, E., Wester, P. and Winblad, B., Transmitter deficits in Alzheimer's disease, Neurochem. Int., 7 (1985) 545-563.
8. [8] Mandel, R.J. and Thal, L.J., Physostigmine improves water maze performance following nucleus basalis magnocellularis lesions in rats, Psychopharmacology, 96 (1988) 421-425.
9. [9] Mandel, R.J., Chen, A.D., Connor, D.J. and Thal, L.J., Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cortical cholinergic markers, J. Pharmacol. Exp. Ther., 251 (1989) 612-619.
10. [10] Mayo, W., Kharouby, M., Le Moal, M. and Simon, H., Memory disturbances following ibotenic acid injections in the nucleus basalis magnocellularis of the rat, Brain Res., 455 (1988) 213-222.
11. [11] Mesulam, M., Mufson, E., Levey, A. and Wainer, B., The cholinergic innervation of the cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata) and hypothalamus in the rhesus monkey, J. Comp. Neurol., 214 (1983) 170.
12. [12] Miyamoto, M., Narumi, S., Nagaoka, A. and Coyle, J.T., Effects of continuous infusion of cholinergic drugs on memory impairment in rats with basal forebrain lesions, J. Pharmacol. Exp. Ther., 248 (1988) 825-835.
13. [13] Mundy, W.R., Barone, S. and Tilson, H.A., Neurotoxic lesions of the nucleus basalis by colchicine: effects on spatial navigation in the water maze, Brain Res., 512 (1990) 221-228.
14. [14] Niigawa, H., Tanimukai, S., Takeda, M., Hariguchi, S. and Nishimura, T., Effects of SDZ ENA 713, novel acetylcholinesterase inhibitor, on learning of rats with basal forebrain lesions, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 19 (1995) 171-186.
15. [15] Palmer, A.M., Francis, P.T., Bowen, D.M., Benton, J.S., Neary, D., Mann, D.M.A. and Snowden, J.S., Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease, Brain Res., 414 (1978) 365-375.
16. [16] Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego, 1986.
17. [17] Perry, E.K., Perry, R.H., Blessed, G. and Tomlinson, B.E., Necropsy evidence of central cholinergic deficits in senile dementia, Lancet, 1 (1977) 189.
18. [18] Perry, E.K., Tomlinson, B.E., Blessed, G., Bergmann, K., Gibson, P.H. and Perry, R.H., Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia, Br. Med. J., 2 (1978) 1457-1459.
19. [19] Rye, D., Wainer, B., Mesulam, M., Mufson, E. and Saper, C., Cortical projections arising from the basal forebrain: a study of cholinergic and noncholinergic components employing combined retrograde tracing and immunohistochemical localization of choline acetyltransferase, Neuroscience, 13 (1984) 627-643.
20. [20] Smith, G., Animal models of Alzheimer's disease: experimental cholinergic denervation, Brain Res. Rev., 13 (1988) 103-118.
21. [21] Tanaka, K., Ogawa, N., Mizukawa, K., Asanuma, M., Kondo, Y., Nishibayashi, S. and Mon, A., Acetylcholinesterase inhibitor ENA-713 protects against ischemia-induced decrease in pre-and postsynaptic cholinergic indices in the gerbil brain following transient ischemia, Neurochem. Res., 19 (1994) 117-122.
22. [22] Tanaka, K., Oh-hara, T., Fukaya, H., Akahane, N., Demura, N. and Seno, N., Ameliorating effects of SDZ ENA 713 on decreased choline acetyltransferase activity in the brains of learning impaired rats, In: Neuromediators and Brain Dysfunction, Satellite Symposium of the 15th International Society for Neurochemistry Meeting, 1995, p. 30.
23. [23] Tanaka, K., Oh-hara, T., Fukaya, H., Demura, N., Iimura, A. and Seno, N., Effects of SDZ ENA-713 on choline acetyltransferase activity and muscarinic acetylcholine receptor binding in the brains of learning impaired rats, Jpn. J. Pharmacol., Suppl., 67 (1995) 306.
24. [24] White, P., Hiley, C.R., Goodhardt, M.J., Carrasco, L.H., Keet, J.P., Williams, I.E.I. and Bowen, D.M., Neocortical cholinergic neurons in elderly people, Lancet, 3 (1977) 668-670.
25. [25] Whitehouse, P.J., Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain, Science, 215 (1982) 1237-1239.